Hematology TimesDisease burden impacts outcome of CAR T-cell therapy in B-ALLApril 7, 2017Leukemia, Myelodysplasia, TransplantationALL
Hematology TimesImmunotherapy exhibits antileukemic activity in high-risk patientsMarch 31, 2017Leukemia, Myelodysplasia, TransplantationALL
Hematology TimesFDA grants priority review to sBLA for blinatumomabMarch 31, 2017Leukemia, Myelodysplasia, TransplantationPharmacyALL
Hematology TimesFDA grants priority review for BLA of CAR T-cell therapyMarch 30, 2017Leukemia, Myelodysplasia, TransplantationALL
Hematology TimesProteins may be therapeutic targets for TKI-resistant CML, ALLMarch 21, 2017Leukemia, Myelodysplasia, TransplantationALLCML
Hematology TimesNew insight into high-hyperdiploid ALLMarch 21, 2017Leukemia, Myelodysplasia, TransplantationPediatricsALL
Hematology TimesMRD predicts outcome of HSCT in ALL, study suggestsMarch 13, 2017Leukemia, Myelodysplasia, TransplantationPediatricsTransplantationALL
Hematology TimesGenetic variants linked to HSCT outcomes in ALLMarch 8, 2017Leukemia, Myelodysplasia, TransplantationTransplantationALL
Hematology TimesStudy reveals higher rate of early death in kids with cancerMarch 7, 2017Leukemia, Myelodysplasia, TransplantationPediatricsAMLALL
Hematology TimesBlinatumomab bests chemo in rel/ref B-ALLMarch 5, 2017Leukemia, Myelodysplasia, TransplantationALL
Hematology NewsMixed leukemias can benefit from allo-HSTMarch 3, 2017AMLALLLeukemia, Myelodysplasia, Transplantation
Hematology NewsPre- and post-HCT MRD levels predict ALL survivalMarch 3, 2017ALLLeukemia, Myelodysplasia, Transplantation
Hematology TimesCAR T-cell trial in adult ALL shut downMarch 3, 2017Leukemia, Myelodysplasia, TransplantationALL
Hematology NewsBlinatumomab superior to chemotherapy for refractory ALLMarch 1, 2017ALLLeukemia, Myelodysplasia, Transplantation
Hematology TimesAcquired mutations may compromise assayFebruary 28, 2017Leukemia, Myelodysplasia, TransplantationALLCML
